Page last updated: 2024-11-08

rhazinicine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

rhazinicine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID639955
CHEMBL ID68701
MeSH IDM0522260

Synonyms (3)

Synonym
rhazinicine
CHEMBL68701
(12s)-12-ethyl-8,16-diazatetracyclo[10.6.1.02,7.016,19]nonadeca-1(19),2,4,6,17-pentaene-9,15-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID311668Cytotoxicity against vincristine-resistant human KB/VJ300 cells in presence of 0.121 uM vincristine2007Journal of natural products, Nov, Volume: 70, Issue:11
Biologically active aspidofractinine, rhazinilam, akuammiline, and vincorine alkaloids from Kopsia.
AID311666Cytotoxicity against vincristine-resistant human KB cells2007Journal of natural products, Nov, Volume: 70, Issue:11
Biologically active aspidofractinine, rhazinilam, akuammiline, and vincorine alkaloids from Kopsia.
AID311667Cytotoxicity against vincristine-resistant human KB/VJ300 cells2007Journal of natural products, Nov, Volume: 70, Issue:11
Biologically active aspidofractinine, rhazinilam, akuammiline, and vincorine alkaloids from Kopsia.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]